Denosumab 120mg
- Brand Names: Prolia®, Xgeva®; biosimilars: Jubbonti®, Wyost®,
- Form: Subcutaneous injection solution (prefilled syringe or vial)
- Strength: 120 mg
- Manufacturer: Amgen (originator) Intas Pharmaceuticals
- Country: India/USA/EU
- MOQ: 5 units
- Shelf Life: 24 Months
- Storage: Refrigerated 2–8 °C; bring to room temp before use
Description
Denosumab is a human monoclonal antibody indicated for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture, bone loss due to hormone ablation in cancer, and for prevention of skeletal-related events in patients with bone metastases from solid tumors. It works by inhibiting RANKL, thereby reducing bone resorption.
